Gastric inhibitory polypeptide receptor (GIPR) directly induces energy accumulation in
adipose tissue in vitro. However, the importance of the direct effect of GIPR signaling on …

Gastric inhibitory polypeptide (GIP) is an incretin and directly promotes fat accumulation in
adipocytes. Inhibition of GIP signaling prevents onset of obesity and increases fat oxidation …

Gut hormone gastric inhibitory polypeptide (GIP) stimulates insulin secretion from pancreatic
β-cells upon ingestion of nutrients. Inhibition of GIP signaling prevents the onset of obesity …

Objective Glucose-dependent insulinotropic polypeptide (GIP) is secreted from the gut in
response to nutrient ingestion and promotes meal-dependent insulin secretion and lipid …

Glucose-dependent insulinotropic polypeptide (GIP) is best known as an incretin hormone
that is secreted from K-cells of the proximal intestine, but evidence also implicates a role for …

Background Intramuscular adipose tissue (IMAT) formation derived from muscle fibro‐
adipogenic progenitors (FAPs) has been recognized as a pathological feature of …

Aims/hypothesis Gastric inhibitory polypeptide (GIP) receptor antagonism with (Pro 3) GIP
improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet …

The gut hormone gastric inhibitory polypeptide (GIP) plays a key role in glucose
homeostasis and lipid metabolism. This study investigated the effects of administration of a …

Aging is associated with increased fat mass and decreased lean mass, which is strongly
associated with the development of insulin resistance. Gastric inhibitory polypeptide (GIP) is …

Glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) has been identified in
multiple genome-wide association studies (GWAS) as a contributor to obesity, and GIPR …